Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Annals of Hematology
Metadata
Title
Therapy of B-cell lymphomas with monoclonal antibodies and radioimmunoconjugates: the Seattle experience
Authors
T. A. Johnson
O. W. Press
Publication date
01-04-2000
Publisher
Springer-Verlag
Published in
Annals of Hematology / Issue 4/2000
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s002770050576

Other articles of this Issue 4/2000

Annals of Hematology 4/2000 Go to the issue

CASE REPORT

An unusual case of leukemic non-Hodgkin's lymphoma with blastic transformation

ORIGINAL ARTICLE

Excellent disease eradication by myeloablative therapy and stem-cell transplantation in patients with acute myelogenous leukemia

OriginalPaper

Erratum: Ann Hematol (2000) 79: 161–164

CASE REPORT

T-cell lineage acute lymphoblastic leukemia with chromosome 5 abnormality in a patient with Crohn's disease and lipoid nephrosis

RAPID COMMUNICATION

Regression of Epstein–Barr virus-associated lymphoproliferative disorders in patients with acquired immunodeficiency syndrome during therapy with foscarnet

ORIGINAL ARTICLE

Aberrant expression of the major sialoglycoprotein (CD43) on the monocytes of patients with myelodysplastic syndromes

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits